“…It is used in the treatment of Parkinson's disease, usually associated with a peripheral aromatic-l-amino acid decarboxylase (AADC) inhibitor, such as benserazide [N -(2,3,4-trihydroxybenzyl)-d,l-serine], in order to increment the proportion that enters the brain [1,2]. Scientific literature reports several methods for the determination of levodopa and benserazide in pharmaceutical preparations and in biological fluids, such as spectrophotometry [3][4][5][6][7][8][9], capillary zone electrophoresis [10,11], high performance liquid chromatography [12][13][14][15] and gas chromatography [16]. Flow injection analysis (FIA) has been applied to the determination of levodopa in mixtures with other drugs [17] and of benserazide in tablets [18].…”